Viking Therapeutics: HC Wainwright Raises PT to $102, Maintains Buy Rating

lunes, 23 de marzo de 2026, 6:31 am ET1 min de lectura
VKTX--

Viking Therapeutics: HC Wainwright Raises PT to $102, Maintains Buy Rating

Viking Therapeutics: HC Wainwright Raises PT to $102, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios